Clinical Trial Update: National Multicenter, Controlled, Single-blind Study With Two Parallel Groups Evaluating the Safety and Efficacy of Sequential Treatment With Mitoxantrone and Interferon Versus Interferon Alone in Patients With Strong Risk of Progression in the Initial Phase of Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing sequential mitoxantrone and interferon versus interferon alone in patients with high progression risk in early multiple sclerosis; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Interferon (interferon)
• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: Rennes University Hospital | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED